Powered by: Motilal Oswal
2026-05-05 02:49:40 pm | Source: Accord Fintech
Shelter Pharma moves up on bagging repeat purchase orders from Taha Drugs & Chemicals Co
Shelter Pharma moves up on bagging repeat purchase orders from Taha Drugs & Chemicals Co

Shelter Pharma is currently trading at Rs. 30.60, up by 0.22 points or 0.72% from its previous closing of Rs. 30.38 on the BSE.

The scrip opened at Rs. 30.00 and has touched a high and low of Rs. 30.60 and Rs. 30.00 respectively. So far 6000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 50.00 on 25-Aug-2025 and a 52 week low of Rs. 26.50 on 30-Mar-2026.

Last one week high and low of the scrip stood at Rs. 31.20 and Rs. 29.00 respectively. The current market cap of the company is Rs. 51.18 crore.

The promoters holding in the company stood at 44.99%, while non-institutions held 55.01% stake in the company.

Shelter Pharma has received repeat international purchase orders from an existing overseas customer, Taha Drugs & Chemicals Co in the normal course of business. The company has received purchase orders for supply of nutraceutical products.

These repeat orders reflect continued trust and satisfaction of the customer in the company’s products and services and signify strengthening business relations in the international market. The development is expected to further enhance the company’s global presence and contribute positively to its revenue and overall business growth. Broad commercial consideration or size of the orders is $84,450. The orders are to be executed within the mutually agreed timelines as per purchase order and shipment schedule.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here